Login to Your Account

Other News To Note

Friday, September 16, 2011
Vaxin Inc., of Rockville, Md., received a $14.7 million contract over two years from the Biomedical Advanced Research and Development Authority for the development of a next-generation anthrax vaccine. The contract could be extended for a total of up to four years and $21.7 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription